default author photo

Hans M. Westgeest

Amphia Hospital - Department of Internal Mediine

P.O. Box 90158

4800 AK Breda

Netherlands

SCHOLARLY PAPERS

4

DOWNLOADS

170

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Phenotype-Guided Targeted Therapy Based on Functional Signal Transduction Pathway Activity in Recurrent Ovarian Cancer Patients: The Stapover Study Protocol

Number of pages: 24 Posted: 18 May 2023
Maastricht University, Catharina Hospital, Catharina Hospital, Amphia Hospital - Department of Internal Mediine, Amphia Hospital, Elisabeth-Tweesteden Hospital - Department of Obstetrics and Gynecology, University of Groningen - Department of Medical Oncology, Medical University of Gdańsk - Department of Oncology and Radiotherapy, Erasmus University Rotterdam (EUR), Radboud University Nijmegen - Radboud University Medical Center, Radboud University, University of Amsterdam - University Medical Center, University of Amsterdam - University Medical Center, Maastricht University, Maastricht University, Catharina Hospital and Catharina Hospital
Downloads 53 (1,031,043)

Abstract:

Loading...

ovarian cancer, signal transduction pathways, Survival, Targeted therapy, off-label drugs

2.

Body Composition Metrics and Immune Related Adverse Events in Advanced Melanoma: A Multicenter Cohort Study

Number of pages: 25 Posted: 07 Nov 2025
Utrecht University, Utrecht University, Utrecht University, Utrecht University, Utrecht University, DeepHealth Inc, University Medical Center Utrecht - Department of Radiation Oncology, Zuyderland Medical Centre, Netherlands Cancer Institute, Zuyderland Medical Centre, Radboud University Nijmegen - Radboud University Medical Center, Isala Zwolle, Isala Zwolle, Netherlands Cancer Institute - Division of Molecular Oncology and Immunology, University of Groningen - University Medical Center Groningen, Medisch Spectrum Twente, Maxima Medical Centre, Amphia Hospital - Department of Internal Mediine, Leiden University Medical Centre, VU University Amsterdam - Department of Medical Oncology, Utrecht University, Utrecht University - Department of Pathology, Utrecht University, Utrecht University, Mayo Clinic, Eindhoven University of Technology (TUE) and Utrecht University - University Medical Center (Utrecht)
Downloads 47 (1,097,529)

Abstract:

Loading...

Melanoma, body composition, body mass index, body composition metrics, skeletal muscle density, sarcopenia, myosteatosis, immune related adverse events, toxicity, Immune checkpoint inhibitors

3.

Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma

Number of pages: 82 Posted: 20 Jul 2021
Erasmus University Medical Center - Department of Urology, Erasmus University Medical Center - Department of Medical Oncology, Erasmus University Medical Center - Cancer Computational Biology Center, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Department of Medical Oncology, Utrecht University - Cancer Genomics Netherlands, Radboud University Medical Center - Department of Medical Oncology, Radboud University Medical Center - Department of Medical Oncology, University Medical Center Groningen - Department of Medical Oncology, Erasmus MC University Medical Center Rotterdam - Department of Pathology, Amphia Hospital - Department of Internal Mediine, Erasmus MC University Medical Center Rotterdam - Department of Pathology, Erasmus University Medical Center - Department of Medical Oncology, Erasmus University Medical Center - Department of Medical Oncology, Erasmus University Medical Center - Department of Urology & Depratment of Immunology, Erasmus University Medical Center - Department of Urology and Erasmus University Medical Center - Department of Urology
Downloads 47 (1,097,529)

Abstract:

Loading...

Molecular Profiling, Neoplasm Metastases, RNA-seq, Urologic Neoplasms, Whole Genome Sequencing

4.

Development and External Validation of a New Prognostic Model for Overall Survival in Metastatic Clear Cell Renal Cell Carcinoma Using Data from Randomized Clinical Trials in the Checkpoint Inhibitor Era

Number of pages: 20 Posted: 11 May 2026
Netherlands Comprehensive Cancer Organisation, Utrecht University - Julius Center for Health Sciences and Primary Care, Amphia Hospital - Department of Internal Mediine, University of Bern - Inselspital, Utrecht University - Julius Center for Health Sciences and Primary Care, Netherlands Comprehensive Cancer Organisation and Netherlands Cancer Institute
Downloads 23 (1,411,822)

Abstract:

Loading...

renal cell carcinoma, first-line treatment, prognostic model, development, external validation, checkpoint inhibitor